Jeevan Kumar
Impact in
-
- Hemoglobinopathies and Related Disorders
Papers in
- Oncology 18
- CAR-T cell therapy research 4
- Hematology 12
- Multiple Myeloma Research and Treatments 4
- Hematopoietic Stem Cell Transplantation 3
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- Vivek Radhakrishnan (14 shared papers)Mukul R. Jain (6 shared papers)Mammen Chandy (11 shared papers)Reena Nair (14 shared papers)Vı́tor Vasconcelos (1 shared paper)Manorama Bhargava (2 shared papers)Deepak Kumar Mishra (10 shared papers)Arijit Nag (10 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (3 papers)Frontiers in Oncology (2 papers)Bioorganic Chemistry (2 papers)European Journal of Medicinal Chemistry (1 paper)Future Oncology (1 paper)
- Partner nations
- IndiaUnited StatesPakistan
In The Last Decade
Jeevan Kumar
38 papers receiving 229 citations
Peers
Comparison fields: 5 of 61
- Hematology 44
- Genetics 35
- Oncology 55
- Organic Chemistry 47
- Pharmaceutical Science 7
Countries citing papers authored by Jeevan Kumar
This map shows the geographic impact of Jeevan Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeevan Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeevan Kumar more than expected).
Fields of papers citing papers by Jeevan Kumar
This network shows the impact of papers produced by Jeevan Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeevan Kumar. The network helps show where Jeevan Kumar may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeevan Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 39 | |
| 2 | 2020 | 19 | |
| 3 | 2018 | 18 | |
| 4 | 2019 | 17 | |
| 5 | 2025 | 14 | |
| 6 | 2018 | 14 | |
| 7 | 2021 | 13 | |
| 8 | 2012 | 12 | |
| 9 | 2018 | 9 | |
| 10 | 2019 | 8 | |
| 11 | 2022 | 7 | |
| 12 | 2025 | 6 | |
| 13 | 2022 | 6 | |
| 14 | 2024 | 5 | |
| 15 | 2020 | 5 | |
| 16 | 2020 | 5 | |
| 17 | 2017 | 5 | |
| 18 | 2022 | 4 | |
| 19 | 2012 | 4 | |
| 20 | 2021 | 4 |
About Jeevan Kumar
Jeevan Kumar is a scholar working on Oncology, Hematology, Pathology and Forensic Medicine, Genetics and Molecular Biology, having authored 46 papers that have together received 241 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (4 papers), Multiple Myeloma Research and Treatments (4 papers), CAR-T cell therapy research (4 papers), Hematopoietic Stem Cell Transplantation (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Diabetes Treatment and Management (3 papers). The work is most often cited by research in Hematology (44 citations), Genetics (35 citations), Oncology (55 citations), Organic Chemistry (47 citations) and Pharmaceutical Science (7 citations). Jeevan Kumar has collaborated with scholars based in India, United States and Pakistan. Frequent co-authors include Vivek Radhakrishnan, Mukul R. Jain, Mammen Chandy, Reena Nair, Vı́tor Vasconcelos, Manorama Bhargava, Deepak Kumar Mishra, Arijit Nag, Shyam Aggarwal and Shubhangi S. Soman. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Frontiers in Oncology, Bioorganic Chemistry, European Journal of Medicinal Chemistry and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.